Effects of losartan and captopril on left ventricular systolic and diastolic function after acute myocardial infarction: Results of the Optimal Trial in Myocardial Infarction with Angiotensin II antagonist losartan (optimaal) echocardiographic substudy

This publication has 26 references indexed in Scilit:

• Prognostic importance of systolic and diastolic function after acute myocardial infarction
  American Heart Journal, 2003
• Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial
  The Lancet, 2002
• The role of the renin-angiotensin system in the development of cardiovascular disease
  The American Journal of Cardiology, 2002
• Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-II antagonism
  Journal of the American College of Cardiology, 1999
• Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial design
  The American Journal of Cardiology, 1999
• Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
  Journal of Clinical Investigation, 1997
• Survival after myocardial infarction in rats: captopril versus losartan
  Journal of the American College of Cardiology, 1996
• A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial Infarction
  New England Journal of Medicine, 1995
• Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
  New England Journal of Medicine, 1992
• Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
  Journal of the American Society of Echocardiography, 1989